Clinical Trial Update: EUS-RFA PANCARDINAL-1 Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update on endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for pancreatic ductal adenocarcinoma is currently recruiting (PANCARDINAL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 2 | Status: RECRUITING